New Horizon Health EBITDA TCAC 3A

Que fait New Horizon Health ? New Horizon Health Ltd. generates revenue through the distribution of its ColoClear and Pupu tube products via its own network, contracted sales organisations (CSOs), and e-platforms managed by healthcare clinics. The company also develops Youyou Tube, a stool-based self-checking gastric cancer screening test, and CerviClear, a non-invasive urine cervical cancer home screening test, which are currently under development. Its primary customers include healthcare clinics and end-users seeking non-invasive cancer screening solutions. The firm's product portfolio focuses on innovative medical screening tools, targeting the growing demand for accessible and user-friendly health diagnostics. By leveraging its internal sales channels and partnerships with CSOs, New Horizon Health Ltd. ensures broad market reach for its products. The company's development of Youyou Tube and CerviClear reflects its strategic emphasis on expanding into high-need areas of cancer prevention and early detection. Revenue streams are derived from the sale of ColoClear and Pupu tube products, with future potential from the commercialization of Youyou Tube and CerviClear once development is complete. The company's business model relies on direct and indirect sales channels to healthcare providers and consumers, positioning it within the medical diagnostics sector. New Horizon Health est l'une des entreprises les plus populaires sur Eulerpool.